|
National Stock Number(NSN): 6505-01-153-3786 (6505011533786, 011533786)
| NIIN: |
01-153-3786 |
Item Name: |
DESIPRAMINE HYDROCHLORIDE CAPSULES,USP |
INC: |
37067
|
| FSC: |
6505
|
Assignment Date: |
|
CRIT: |
|
IIG: |
37067 |
| ISC: |
C |
Date Standardized: |
|
HMIC: |
|
DODIC: |
|
| NSC: |
8 |
Cancellation Date: |
May-21-1997 |
PMIC: |
A |
FIIG: |
A45000 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
E |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
|
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
351-999 |
04689
|
USV PHARMACEUTICAL CORP DIV OF WILLIAM H RORER INC |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
NDC00070-0160-99 |
04689
|
USV PHARMACEUTICAL CORP DIV OF WILLIAM H RORER INC |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
PERTOFRANE |
04689
|
USV PHARMACEUTICAL CORP DIV OF WILLIAM H RORER INC |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
PERTOFRANE CAPSULES |
04689
|
USV PHARMACEUTICAL CORP DIV OF WILLIAM H RORER INC |
H |
5 |
1 |
|
|
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DN |
S9M |
Y |
|
0 |
|
1 |
|
$104.38 |
BT |
|
9L----- |
|
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DN |
V |
Discontinued without Replacement |
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
25.000 MILLIGRAMS DESIPRAMINE HYDROCHLORIDE ACTIVE INGREDIENT |
| AKJC |
CAPSULE TYPE |
ANY ACCEPTABLE |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CQLS |
CAPSULE CONTENT FORM |
ANY ACCEPTABLE |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
1000.000 CAPSULES |
| SUPP |
SUPPLEMENTARY FEATURES |
MEDSEP ITEM FOR DOD,USV PHARMACEUTICAL CORP |
|